Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,731 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma.
Kanda M, Murotani K, Sugimoto H, Miwa T, Umeda S, Suenaga M, Hayashi M, Hattori N, Tanaka C, Kobayashi D, Yamada S, Fujiwara M, Kodera Y. Kanda M, et al. Among authors: sugimoto h. Oncotarget. 2017 Aug 19;8(41):71070-71079. doi: 10.18632/oncotarget.20369. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050343 Free PMC article.
Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
Kanda M, Shimizu D, Tanaka H, Shibata M, Iwata N, Hayashi M, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Kanda M, et al. Among authors: sugimoto h. Oncotarget. 2016 Mar 22;7(12):13667-79. doi: 10.18632/oncotarget.7269. Oncotarget. 2016. PMID: 26872374 Free PMC article.
The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy.
Shimizu D, Kanda M, Sugimoto H, Shibata M, Tanaka H, Takami H, Iwata N, Hayashi M, Tanaka C, Kobayashi D, Yamada S, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. Shimizu D, et al. Among authors: sugimoto h. Int J Oncol. 2017 Feb;50(2):381-386. doi: 10.3892/ijo.2017.3833. Epub 2017 Jan 2. Int J Oncol. 2017. PMID: 28101581 Free PMC article.
Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis.
Hishida M, Nomoto S, Inokawa Y, Hayashi M, Kanda M, Okamura Y, Nishikawa Y, Tanaka C, Kobayashi D, Yamada S, Nakayama G, Fujii T, Sugimoto H, Koike M, Fujiwara M, Takeda S, Kodera Y. Hishida M, et al. Among authors: sugimoto h. Int J Oncol. 2013 Jul;43(1):88-94. doi: 10.3892/ijo.2013.1951. Epub 2013 May 20. Int J Oncol. 2013. PMID: 23695389
Detection of doublecortin domain-containing 2 (DCDC2), a new candidate tumor suppressor gene of hepatocellular carcinoma, by triple combination array analysis.
Inokawa Y, Nomoto S, Hishida M, Hayashi M, Kanda M, Nishikawa Y, Takeda S, Sugimoto H, Fujii T, Yamada S, Kodera Y. Inokawa Y, et al. Among authors: sugimoto h. J Exp Clin Cancer Res. 2013 Sep 14;32(1):65. doi: 10.1186/1756-9966-32-65. J Exp Clin Cancer Res. 2013. PMID: 24034596 Free PMC article.
Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis.
Inokawa Y, Nomoto S, Hishida M, Hayashi M, Kanda M, Nishikawa Y, Takeda S, Fujiwara M, Koike M, Sugimoto H, Fujii T, Nakayama G, Yamada S, Tanaka C, Kobayashi D, Kodera Y. Inokawa Y, et al. Among authors: sugimoto h. Onco Targets Ther. 2013 Oct 9;6:1417-24. doi: 10.2147/OTT.S51913. eCollection 2013. Onco Targets Ther. 2013. PMID: 24143113 Free PMC article.
1,731 results